The 3p21.31 genetic locus promotes progression to type 1 diabetes through the CCR2/CCL2 pathway
Multiple cross-sectional and longitudinal studies have shown that serum levels of the chemokine ligand 2 (CCL-2) are associated with type 1 diabetes (T1D), although the direction of effect differs. We assessed CCL-2 serum levels in a longitudinal cohort to clarify this association, combined with gen...
Main Authors: | Paul MH. Tran, Sharad Purohit, Eileen Kim, Khaled bin Satter, Diane Hopkins, Kathleen Waugh, Fran Dong, Suna Onengut-Gumuscu, Stephen S. Rich, Marian Rewers, Jin-Xiong She |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Journal of Translational Autoimmunity |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589909021000472 |
Similar Items
-
Targeting CCL2-CCR2 Signaling Axis in Cancer Therapy
by: LU Xiaomei, et al.
Published: (2019-05-01) -
Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
by: Suguru Kadomoto, et al.
Published: (2021-08-01) -
Role of the CCL2-CCR2 axis in cardiovascular disease: Pathogenesis and clinical implications
by: Haixia Zhang, et al.
Published: (2022-08-01) -
An Alternative Perspective to the FMF Clinic: MCP-1 (A-2518G) and CCR2 (G190A) Polymorphisms and MCP1 Expression
by: Nadir Koçak, et al.
Published: (2022-09-01) -
<i>CCL2</i>, <i>CCR2</i> Gene Variants and CCL2, CCR2 Serum Levels Association with Age-Related Macular Degeneration
by: Gaile Gudauskiene, et al.
Published: (2022-07-01)